For the quarter ending 2026-03-31, HIPOW had $54,700K increase in cash & cash equivalents over the period. $8,400K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income (loss) | - | 62,600 | - |
| Depreciation and amortization | - | 20,400 | - |
| Stockbased compensation expense | - | 29,300 | - |
| Fair value adjustments | - | 600 | - |
| Impairment and restructuring charges | - | 5,000 | - |
| Gain on sale of business | - | 95,000 | - |
| Other non-cash items | - | 8,300 | - |
| Accounts receivable, net | - | 85,400 | - |
| Reinsurance recoverables | - | 61,300 | - |
| Ceding commissions receivable | - | 19,200 | - |
| Prepaid reinsurance premiums | - | 79,500 | - |
| Other assets | - | 16,200 | - |
| Provision for commission | - | 2,000 | - |
| Accrued expenses and other liabilities | - | 7,400 | - |
| Losses and loss adjustment expense reserves | - | 70,400 | - |
| Unearned premiums | - | 121,800 | - |
| Reinsurance premiums payable | - | 55,800 | - |
| Net cash provided by (used in) operating activities | 8,500 | 3,200 | 6,000 |
| Capitalized internal use software costs | 3,100 | 3,500 | 9,700 |
| Purchases of property and equipment | 100 | 0 | 100 |
| Purchases of fixed maturities | 29,400 | 65,800 | 72,600 |
| Maturities of fixed maturities | 20,900 | 20,100 | 31,500 |
| Sales of fixed maturities | 1,100 | 1,700 | 1,200 |
| Purchases of short-term investments | 65,300 | 60,600 | 227,000 |
| Maturities of short-term investments | 91,400 | 79,100 | 220,300 |
| Sales of short-term investments | 2,000 | 3,300 | 5,100 |
| Proceeds from sale of business, net | - | 0 | 65,800 |
| Proceeds from deferred consideration | -25,000 | 0 | 0 |
| Net cash provided by (used in) investing activities | 42,500 | -25,700 | 14,500 |
| Proceeds from surplus note, net | - | 0 | 47,900 |
| Taxes paid related to net share settlement of equity awards | 0 | 0 | 9,400 |
| Proceeds from issuance of common stock | 1,000 | 1,000 | 2,800 |
| Share repurchases under program | - | 0 | 14,500 |
| Payments of contingent consideration | 0 | 0 | 400 |
| Acquisitions of noncontrolling interests | - | 0 | 0 |
| Distributions to noncontrolling interests | 0 | - | - |
| Distributions to noncontrolling interests and other | - | 600 | 7,500 |
| Other | 2,700 | - | - |
| Net cash provided by (used in) financing activities | 3,700 | 400 | 18,900 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 54,700 | -22,100 | 39,400 |
| Cash, cash equivalents, and restricted cash at the beginning of the period | 250,100 | 272,200 | 232,800 |
| Cash, cash equivalents, and restricted cash at the end of the period | 304,800 | 250,100 | 272,200 |